$KSEZ
Kinetic Seas Inc.

2024 Q3 Form 10-Q Financial Statement

#000168316824005863 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $64.97K $61.77K
YoY Change
Cost Of Revenue $52.49K $46.42K
YoY Change
Gross Profit $12.48K $15.35K
YoY Change
Gross Profit Margin 19.2% 24.85%
Selling, General & Admin $134.1K $253.3K
YoY Change 673.04% 1040.92%
% of Gross Profit 1074.73% 1650.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.056M $458.2K
YoY Change 5987.46% 1963.56%
Operating Profit -$1.043M -$442.9K
YoY Change 5915.53% 1894.42%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$10.13K -$14.72K
YoY Change -5.21% 73.42%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.054M -$457.6K
YoY Change 3658.94% 1390.74%
Net Earnings / Revenue -1621.65% -740.77%
Basic Earnings Per Share -$0.06 -$0.02
Diluted Earnings Per Share -$0.06 -$0.02
COMMON SHARES
Basic Shares Outstanding 16.74M shares 31.15M shares
Diluted Shares Outstanding 16.86M shares 24.09M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $13.97K $60.23K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $20.82K $20.04K
Other Receivables
Total Short-Term Assets $58.27K $90.28K
YoY Change 1381.29% 1665.94%
LONG-TERM ASSETS
Property, Plant & Equipment $93.54K $103.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $93.54K $103.0K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $58.27K $90.28K
Total Long-Term Assets $93.54K $103.0K
Total Assets $151.8K $193.3K
YoY Change 3758.92% 3680.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.7K $24.70K
YoY Change 4569.14% 123.91%
Accrued Expenses $33.49K $241.0K
YoY Change 0.0% 619.66%
Deferred Revenue
YoY Change
Short-Term Debt $150.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $487.2K $578.5K
YoY Change 115.46% 190.3%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $487.2K $578.5K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.828M -$1.775M
YoY Change 176.5% 78.39%
Common Stock $170.00 $165.00
YoY Change 466.67% 450.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$335.4K -$385.2K
YoY Change
Total Liabilities & Shareholders Equity $151.8K $193.3K
YoY Change 3758.92% 3680.71%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.054M -$457.6K
YoY Change 3658.94% 1390.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17931 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-457582 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
901-8806
dei Security12g Title
Security12gTitle
Common Stock
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16737000 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60233 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20042 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
10000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
0 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
90275 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
17931 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102995 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13141 usd
CY2024Q2 us-gaap Assets
Assets
193270 usd
CY2023Q4 us-gaap Assets
Assets
31072 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
24702 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
240986 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1346 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
11098 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
150000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2024Q2 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
161469 usd
CY2023Q4 ECGR Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
182000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
578502 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
226584 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
19450 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
19450 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16540000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16540000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26646000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26646000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
165 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
266 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1389321 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
922020 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1774718 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1117798 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-385232 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-195512 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193270 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31072 usd
CY2024Q2 us-gaap Revenues
Revenues
61771 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
72325 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
46418 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
54259 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
15353 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
18066 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
253342 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22205 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
345547 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24931 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
97539 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
119533 usd
us-gaap Professional Fees
ProfessionalFees
0 usd
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
77648 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
0 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
142177 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
0 usd
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
29683 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
48456 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
458213 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
22205 usd
us-gaap Operating Expenses
OperatingExpenses
655713 usd
us-gaap Operating Expenses
OperatingExpenses
24931 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-442860 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-22205 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-637648 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-24931 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
14723 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8490 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
19273 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
13086 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14723 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8490 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19273 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13086 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-30695 usd
us-gaap Net Income Loss
NetIncomeLoss
-656920 usd
us-gaap Net Income Loss
NetIncomeLoss
-38017 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24093000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24093000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3046000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3046000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26619500 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26619500 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3046000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3046000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-156149 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7322 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-163471 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-30695 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-194166 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-195512 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
250000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-199338 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-144850 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2000 usd
CY2024Q2 ECGR Common Stock Issued In Error To Be Returned
CommonStockIssuedInErrorToBeReturned
10000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
205200 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-457582 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-385232 usd
us-gaap Net Income Loss
NetIncomeLoss
-656920 usd
us-gaap Net Income Loss
NetIncomeLoss
-38017 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11998 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20042 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24702 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1334 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
9752 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
207500 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13085 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-440515 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26265 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
101852 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101852 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
20531 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
455200 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
584669 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
42302 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3735 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17931 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1376 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60233 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5111 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zGdvBKj42I7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_z8ngjJ5Bj0jf">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of accrued liabilities and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable and the allowance for doubtful accounts, inventories, and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p>
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60233 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17931 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1774718 usd
CY2024Q2 ECGR Working Capital
WorkingCapital
-488227 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
240986 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33486 usd
CY2024Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
200000 usd
us-gaap Interest Expense
InterestExpense
19273 usd
CY2024Q2 ECGR Notes Payable Related Party Current
NotesPayableRelatedPartyCurrent
161439 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
1346 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16540000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26646000 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse split of 1 for 100
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-005863-index-headers.html Edgar Link pending
0001683168-24-005863-index.html Edgar Link pending
0001683168-24-005863.txt Edgar Link pending
0001683168-24-005863-xbrl.zip Edgar Link pending
ecgr-20240630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kinetic_ex3101.htm Edgar Link pending
kinetic_ex3201.htm Edgar Link pending
kinetic_i10q-63024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ecgr-20240630_cal.xml Edgar Link unprocessable
ecgr-20240630_def.xml Edgar Link unprocessable
ecgr-20240630_lab.xml Edgar Link unprocessable
ecgr-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
kinetic_i10q-63024_htm.xml Edgar Link completed